Association of lung immune prognostic index with survival outcome in advanced thymic carcinoma patients treated with palliative intent chemotherapy.
Taisuke ArakiKazunari TateishiMasamichi KomatsuKei SoneharaShintaro KandaMasayuki HanaokaTomonobu KoizumiPublished in: Thoracic cancer (2022)
Our study indicates that the LIPI is a potential prognostic marker in patients with advanced or recurrent thymic carcinoma undergoing palliative chemotherapy.